oral semaglutide for obesity GLP-1 receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and care. Amid the enthusiasm, however, a quieter and clinically important issue is Amanda Bonello interviews Sabina SIZE:30mg firm

oral semaglutide for obesity GLP-1 receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and care. Amid the enthusiasm, however, a quieter and clinically important issue is Amanda Bonello interviews Sabina SIZE:30mg firm

Amanda Bonello interviews Sabina Hemmi, founder of GLP Winner, about the Safe Drugs Act and state bills threatening compounded GLP-1 access, including semaglutide and tirzepatide, and what patients can do to protect

Nogrady B (2026)

firm

SIZE:30mg

The STEP 4 extension showed about two-thirds of weight lost was regained within a year of stopping semaglutide